The Gairdner Foundation, in partnership with Life Sciences British Columbia and presented by TELUS Health, are hosting a Gairdner Global Perspective Panel on the future of therapeutics. Recently thrust into the global spotlight after forty years in the making, the tiny bubbles of fat known as lipid nanoparticles are what protects and delivers the mRNA COVID-19 vaccines. Without them, there would be no mRNA vaccine, let alone one so effective that shocked the scientific community.
And it doesn't end there. This breakthrough provided a glimpse of the promise and impact that gene therapy medicine, enabled by the technology of lipid nanoparticles, has for human health. Touted as the next generation of medicine, gene therapy has the potential to revolutionize treatment and dramatically improve quality of life by targeting the underlying cause of a genetic disease.
So what does the future hold? Join us in the Science Theatre (located on level 2) as 2022 Gairdner Awards laureate Dr. Pieter Cullis explores this question in his keynote at this Gairdner Global Perspectives Panel. Following Dr. Cullis's keynote, there will be a panel discussion on the future of therapeutics where he will be joined by Drs. James Taylor, Sherie Duncan and Thomas Madden, and moderated by Tiffany Chiu.